Literature DB >> 21609713

Quantum dots-based double-color imaging of HER2 positive breast cancer invasion.

Xiu-Li Liu1, Chun-Wei Peng, Chuang Chen, Xue-Qin Yang, Ming-Bai Hu, He-Shun Xia, Shao-Ping Liu, Dai-Wen Pang, Yan Li.   

Abstract

It has been well recognized that human epidermal growth factor receptor 2 (HER2) level in breast cancer (BC) is closely related to the malignant biologic behaviors of the tumor, including invasion and metastasis. Yet, there has been a lack of directly observable evidence to support such notion. Here we report a quantum dots (QDs)-based double-color imaging technique to simultaneously show the HER2 level on BC cells and the type IV collagen in the tumor matrix. In benign breast tumor, the type IV collagen was intact. With the increasing of HER2 expression level, there has been a progressive decrease in type IV collagen around the cancer nest. At HER2 (3+) expression level, there has virtually been a total destruction of type IV collagen. Moreover, HER2 (3+) BC cells also show direct invasion into the blood vessels. This novel imaging method provides direct observable evidence to support the theory that the HER2 expression level is directly related to BC invasion.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21609713     DOI: 10.1016/j.bbrc.2011.05.052

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Antibody-based imaging of HER-2: moving into the clinic.

Authors:  R E Wang; Y Zhang; L Tian; W Cai; J Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 2.  Quantum dots for quantitative imaging: from single molecules to tissue.

Authors:  Tania Q Vu; Wai Yan Lam; Ellen W Hatch; Diane S Lidke
Journal:  Cell Tissue Res       Date:  2015-01-27       Impact factor: 5.249

Review 3.  Quantum Dot-Based Simultaneous Multicolor Imaging.

Authors:  Wenxia Wang; Zhen Liu; Xiaoli Lan
Journal:  Mol Imaging Biol       Date:  2020-08       Impact factor: 3.488

4.  Overexpression of short TRPM8 variant α promotes cell migration and invasion, and decreases starvation-induced apoptosis in prostate cancer LNCaP cells.

Authors:  Mou Peng; Zijun Wang; Zhonghua Yang; Liu Tao; Qingliang Liu; L U Yi; Xinghuan Wang
Journal:  Oncol Lett       Date:  2015-06-16       Impact factor: 2.967

Review 5.  Quantum dots in biomedical applications.

Authors:  Angela M Wagner; Jennifer M Knipe; Gorka Orive; Nicholas A Peppas
Journal:  Acta Biomater       Date:  2019-05-11       Impact factor: 8.947

6.  Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer.

Authors:  Hong-Mei Zheng; Chuang Chen; Xin-Hong Wu; Jian Chen; Si Sun; Jin-Zhong Sun; Ming-Wei Wang; Sheng-Rong Sun
Journal:  Tumour Biol       Date:  2015-09-19

Review 7.  Inorganic nanoparticles in diagnosis and treatment of breast cancer.

Authors:  Cristina Núñez; Sergio Vázquez Estévez; María Del Pilar Chantada
Journal:  J Biol Inorg Chem       Date:  2018-02-16       Impact factor: 3.358

8.  Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer.

Authors:  Xianda Zhao; Yuyu He; Jun Gao; Lifang Fan; Zonghuan Li; Guifang Yang; Honglei Chen
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

9.  Quantum dots for cancer research: current status, remaining issues, and future perspectives.

Authors:  Min Fang; Chun-Wei Peng; Dai-Wen Pang; Yan Li
Journal:  Cancer Biol Med       Date:  2012-09       Impact factor: 4.248

10.  Quantum dots-based immunofluorescent imaging of stromal fibroblasts Caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancer.

Authors:  Yuyu He; Xianda Zhao; Jun Gao; Lifang Fan; Guifang Yang; William Chi-Shing Cho; Honglei Chen
Journal:  Int J Mol Sci       Date:  2012-10-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.